Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The relationship between cerebellar functional connectivity alterations and hand dexterity impairment in multiple sclerosis.

Journal of neurology·2026
Same author

Anti-CD20 Therapies in Pediatric Acquired Demyelinating Syndromes: Evidence Across MS, AQP4-IgG-Positive NMOSD and MOGAD.

CNS drugs·2026
Same author

T1W/T2W Ratio to Assess Brain Microstructural Damage in Multiple Sclerosis: A Multicenter Study.

AJNR. American journal of neuroradiology·2026
Same author

An automated quantitative report for multiple sclerosis using only 3D T2-fluid-attenuated inversion recovery MRI.

Neuroradiology·2026
Same author

Structural MRI signature of late- versus adult-onset multiple sclerosis: a multiparametric study.

Journal of neurology·2026
Same author

Lifespan Modeling of Choroid Plexus Volume in Multiple Sclerosis and Its Dynamic Associations With Clinical, MRI, and HLA Susceptibility.

Neurology(R) neuroimmunology & neuroinflammation·2026

Related Experiment Video

Updated: Sep 27, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.2K

Pediatric multiple sclerosis: developments in timely diagnosis and prognostication.

Monica Margoni1,2, Paolo Preziosa1,3, Maria A Rocca1,3,4

  • 1Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Expert Review of Neurotherapeutics
|April 11, 2022
PubMed
Summary
This summary is machine-generated.

Pediatric-onset multiple sclerosis (MS) is a severe condition impacting young patients. Early diagnosis and treatment are crucial for managing long-term disability and understanding disease progression.

Keywords:
MRIPediatric multiple sclerosisdiagnostic criteriaprognostic factors

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.2K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.2K

Related Experiment Videos

Last Updated: Sep 27, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.2K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.2K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.2K

Area of Science:

  • Neuroimmunology
  • Pediatric Neurology

Background:

  • Pediatric-onset multiple sclerosis (MS) comprises 2-10% of all MS cases.
  • Recent advancements have improved understanding of POMS pathophysiology, diagnosis, and prognosis.

Purpose of the Study:

  • To review current knowledge on POMS pathophysiology, diagnostic criteria, and prognostic markers.
  • To highlight the impact of POMS on brain maturation and long-term disability.

Main Methods:

  • Literature review of recent updates on POMS.
  • Analysis of clinical, neuroradiological, and laboratoristic markers for disease progression.

Main Results:

  • PO MS presents with significant early clinical and radiological activity.
  • Patients experience disability accumulation at a younger age compared to adults.
  • Brain plasticity's role in counterbalancing damage is under investigation.

Conclusions:

  • PO MS requires early and accurate diagnosis and treatment.
  • Understanding POMS aids in comprehending MS pathogenesis and brain development impacts.
  • Identifying prognosticators is key to managing long-term outcomes in pediatric MS patients.